la antigen
Recently Published Documents


TOTAL DOCUMENTS

67
(FIVE YEARS 2)

H-INDEX

24
(FIVE YEARS 0)

2021 ◽  
Vol 22 (21) ◽  
pp. 12046
Author(s):  
Tabea Bartsch ◽  
Claudia Arndt ◽  
Liliana R. Loureiro ◽  
Alexandra Kegler ◽  
Edinson Puentes-Cala ◽  
...  

The anti-La mab 312B, which was established by hybridoma technology from human-La transgenic mice after adoptive transfer of anti-human La T cells, immunoprecipitates both native eukaryotic human and murine La protein. Therefore, it represents a true anti-La autoantibody. During maturation, the anti-La mab 312B acquired somatic hypermutations (SHMs) which resulted in the replacement of four aa in the complementarity determining regions (CDR) and seven aa in the framework regions. The recombinant derivative of the anti-La mab 312B in which all the SHMs were corrected to the germline sequence failed to recognize the La antigen. We therefore wanted to learn which SHM(s) is (are) responsible for anti-La autoreactivity. Humanization of the 312B ab by grafting its CDR regions to a human Ig backbone confirms that the CDR sequences are mainly responsible for anti-La autoreactivity. Finally, we identified that a single amino acid replacement (D > Y) in the germline sequence of the CDR3 region of the heavy chain of the anti-La mab 312B is sufficient for anti-La autoreactivity.


2021 ◽  
Vol 22 (3) ◽  
pp. 1198
Author(s):  
Michael P. Bachmann ◽  
Tabea Bartsch ◽  
Claudia C. Bippes ◽  
Dominik Bachmann ◽  
Edinson Puentes-Cala ◽  
...  

Since the first description of nuclear autoantigens in the late 1960s and early 1970s, researchers, including ourselves, have found it difficult to establish monoclonal antibodies (mabs) against nuclear antigens, including the La/SS-B (Sjögrens’ syndrome associated antigen B) autoantigen. To date, only a few anti-La mabs have been derived by conventional hybridoma technology; however, those anti-La mabs were not bona fide autoantibodies as they recognize either human La specific, cryptic, or post-translationally modified epitopes which are not accessible on native mouse La protein. Herein, we present a series of novel murine anti-La mabs including truly autoreactive ones. These mabs were elicited from a human La transgenic animal through adoptive transfer of T cells from non-transgenic mice immunized with human La antigen. Detailed epitope and paratope analyses experimentally confirm the hypothesis that somatic hypermutations that occur during T cell dependent maturation can lead to autoreactivity to the nuclear La/SS-B autoantigen.


2017 ◽  
Vol 37 (10) ◽  
Author(s):  
Nathan H. Blewett ◽  
James R. Iben ◽  
Sergei Gaidamakov ◽  
Richard J. Maraia

ABSTRACT Human La antigen (Sjögren's syndrome antigen B [SSB]) is an abundant multifunctional RNA-binding protein. In the nucleoplasm, La binds to and protects from 3′ exonucleases, the ends of precursor tRNAs, and other transcripts synthesized by RNA polymerase III and facilitates their maturation, while a nucleolar isoform has been implicated in rRNA biogenesis by multiple independent lines of evidence. We showed previously that conditional La knockout (La cKO) from mouse cortex neurons results in defective tRNA processing, although the pathway(s) involved in neuronal loss thereafter was unknown. Here, we demonstrate that La is stably associated with a spliced pre-tRNA intermediate. Microscopic evidence of aberrant nuclear accumulation of 5.8S rRNA in La cKO is supported by a 10-fold increase in a pre-5.8S rRNA intermediate. To identify pathways involved in subsequent neurodegeneration and loss of brain mass in the cKO cortex, we employed mRNA sequencing (mRNA-Seq), immunohistochemistry, and other approaches. This revealed robust enrichment of immune and astrocyte reactivity in La cKO cortex. Immunohistochemistry, including temporal analyses, demonstrated neurodegeneration, followed by astrocyte invasion associated with immune response and decreasing cKO cortex size over time. Thus, deletion of La from postmitotic neurons results in defective pre-tRNA and pre-rRNA processing and progressive neurodegeneration with loss of cortical brain mass.


PLoS ONE ◽  
2014 ◽  
Vol 9 (7) ◽  
pp. e101993 ◽  
Author(s):  
Xia Jiang ◽  
Tatsuo Kanda ◽  
Shuang Wu ◽  
Shingo Nakamoto ◽  
Kengo Saito ◽  
...  

2014 ◽  
Vol 4 (1) ◽  
pp. 2 ◽  
Author(s):  
Alexander H Staudacher ◽  
Fares Al-Ejeh ◽  
Cara K Fraser ◽  
Jocelyn M Darby ◽  
David M Roder ◽  
...  

Author(s):  
Haifeng Weng ◽  
Chul Kim ◽  
Christos Valavanis ◽  
Zhaohui Wang ◽  
Lawrence Schwartz

AbstractAcheron, a Lupus antigen ortholog, was identified as a novel death-associated transcript from the intersegmental muscles of the mothManduca sexta. Acheron is phylogenetically-conserved and represents a new sub-family of Lupus antigen proteins. Acheron is expressed predominantly in neurons and muscle in vertebrates, and regulates several developmental events including myogenesis, neurogenesis and possibly metastasis. Using Acheron as bait, we performed a yeast two-hybrid screen with a mouse embryo cDNA library and identified CASK-C, a novel CASK/Lin-2 isoform, as an Acheron binding partner. Acheron and CASK-C bind via the C-terminus of Acheron and the CaMKII-like domain of CASK-C. Co-immunoprecipitation assays verify this interaction and demonstrate that Acheron also forms a complex with all members of the Id (inhibitor of differentiation) proteins. Taken together, these data suggest a mechanism by which Acheron may regulate development and pathology.


Author(s):  
Haifeng Weng ◽  
Chul Kim ◽  
Christos Valavanis ◽  
Zhaohui Wang ◽  
Lawrence Schwartz

Cancer Cell ◽  
2003 ◽  
Vol 3 (2) ◽  
pp. 145-160 ◽  
Author(s):  
Rossana Trotta ◽  
Tatiana Vignudelli ◽  
Olivia Candini ◽  
Robert V. Intine ◽  
Luisa Pecorari ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document